- Tytuł:
- Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
- Autorzy:
- Źródło:
- Molecular Oncology; May2022, Vol. 16 Issue 10, p2057-2070, 19p
Czasopismo naukowe